Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 726,411 | 700,966 | 674,978 | 666,823 | 541,533 |
| Cost of Goods | 149,749 | 170,428 | 184,669 | 199,295 | 140,255 |
| Gross Profit | 576,662 | 530,538 | 490,309 | 467,528 | 401,278 |
| Operating Expenses | 558,220 | 604,337 | 403,303 | 407,799 | 311,609 |
| Operating Income | 19,191 | -73,371 | 87,675 | 60,024 | 89,924 |
| Interest Expense | 17,446 | 16,569 | 20,306 | 39,976 | 31,750 |
| Other Income | 15,129 | 26,834 | -5,668 | -6,746 | -1,770 |
| Pre-tax Income | 16,874 | -63,106 | 61,701 | 13,302 | 56,404 |
| Income Tax | 9,840 | 36,454 | 19,746 | -2,607 | 14,424 |
| Net Income Continuous | 7,034 | -99,560 | 41,955 | 15,909 | 41,980 |
| Net Income | $7,034 | $-99,560 | $41,955 | $15,909 | $41,980 |
| EPS Basic Total Ops | 0.16 | -2.15 | 0.91 | 0.35 | 0.95 |
| EPS Basic Continuous Ops | 0.16 | -2.15 | 0.91 | 0.35 | 0.95 |
| EPS Diluted Total Ops | 0.16 | -2.15 | 0.89 | 0.34 | 0.92 |
| EPS Diluted Continuous Ops | 0.16 | -2.15 | 0.81 | 0.34 | 0.92 |
| EPS Diluted Before Non-Recurring Items | 1.64 | 2.34 | 2.09 | 1.84 | 2.26 |
| EBITDA(a) | $108,284 | $1,215 | $162,421 | $158,732 | $144,378 |